Pharmaceutical computational chemists leverage advanced computational techniques and molecular modeling tools to accelerate drug discovery and development. By simulating molecular interactions, predicting chemical properties, and designing novel compounds, they help identify promising drug candidates before costly laboratory synthesis and testing. These scientists use methods such as molecular docking, quantum mechanics, and molecular dynamics to understand the behavior of drug molecules and their targets at the atomic level. Their work significantly reduces the time and cost associated with bringing new medications to market, improving efficiency in pharmaceutical research.
Pharmaceutical computational chemists analyze the pharmacokinetics and toxicity profiles of compounds using in silico models, helping to predict how drugs will behave in the human body. They collaborate closely with medicinal chemists, biologists, and pharmacologists to optimize drug candidates and guide experimental efforts. As artificial intelligence and machine learning technologies advance, computational chemists increasingly integrate these tools to enhance predictive accuracy and streamline drug development pipelines. Their expertise is crucial in bridging theoretical chemistry and practical application, driving innovation and improving the success rate of new therapeutic agents. Their contributions are pivotal in shaping the future of personalized medicine and targeted therapies. Furthermore, their work supports the pharmaceutical industry’s efforts to meet evolving regulatory requirements and market demands.
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Development of novel drug delivery pathways enabled by perillyl alcohol (NEO100), A monoterpene with multifaceted biomedical applications
Axel H Schonthal, University of Southern California, United States
Title : From marker to mechanism: Ligand discovery enables functional analysis of OR51E1, an ectopic olfactory receptor, in prostate cancer
Vladlen Slepak, University of Miami, United States
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N D Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : R&D consultancy at the medicines discovery catapult: De-risking drug discovery for innovators
Adriana Gambardella, Medicine Discovery Catapult, United Kingdom
Title : Biocompatible synthesis of non crystalline iron oxide nanoparticles with stable colloidal properties
Lan Wang, Paretor LLC, United States
Title : Hydrogen sulfide in sepsis: From bench to bedside
Madhav Bhatia, University of Otago, New Zealand
Title : Biocompatibility and subcutaneous host response to silk fibroin–chitosan composite plugs: Progress toward biodegradable implant materials
Luis Jesus Villarreal Gomez, Universidad Autónoma de Baja California, Mexico